ArticleJournal of cancer research and clinical oncology2021

Response rate and safety in patients with hepatocellular carcinoma treated with transarterial chemoembolization using 40-µm doxorubicin-eluting microspheres.

Katharina Carolin Albrecht et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.